Document is current
Any future updates will be listed below
-
Authors
Nomura, Natsuko
Matsumoto, Hisako
Yokoyama, Akihito
Nishimura, Yoshihiro
Asano, Koichiro
Niimi, Akio
Tohda, Yuji
Harada, Norihiro
Nagase, Hiroyuki
Nagata, Makoto
Inoue, Hiromasa
Kondo, Mitsuko
Horiguchi, Takahiko
Miyahara, Nobuaki
Hizawa, Nobuyuki
Hojo, Masayuki
Hattori, Noboru
Hashimoto, Naozumi
Yamasaki, Akira
Kadowaki, Toru
Kimura, Tomoki
Miki, Mari
Taniguchi, Hirokazu
Toyoshima, Mikio
Kawamura, Tetsuji
Matsuno, Osamu
Sato, Yoko
Sunadome, Hironobu
Nagasaki, Tadao
Oguma, Tsuyoshi
Hirai, Toyohiro
,
Ohnishi, Hisashi
Imaizumi, Kazuyoshi
Fujita, Masaki
Suda, Takafumi
Takaki, Yoichi
Kijima, Takashi
Tobino, Kazunori
Hoshino, Makoto
Imokawa, Shiro
Hiraoka, Noriya
Sugita, Takakazu
Ikeda, Naomi Miho
Ohnishi, Kayoko Okamura Hisashi
Terada-Hirashima, Junko
Isogai, Sumito
Imaizumi, Kazuyoshi
Hirano, Ryosuke
Fujita, Masaki
Fujisawa, Tomoyuki
Suda, Takafumi
Takaki, Yoichi
Higaki, Naoko
Miyamoto, Shintaro
Nakashima, Taku
Iwamoto, Hiroshi
Mikami, Koji
Minami, Toshiyuki
Takahashi, Ryo
Kijima, Takashi
Tobino, Kazunori
Hoshino, Makoto
Imokawa, Shiro
Tsuji, Taisuke
Hiraoka, Noriya
Ikeue, Tatsuyoshi
Sugita, Takakazu
Kunichika, Naomi
Tomari, Shinya
Okochi, Yasumi
Mato, Naoko
Hagiwara, Koichi
Dobashi, Kunio
Taooka, Yasuyuki
Machida, Kentaro
Tanosaki, Takae
Masaki, Katsunori
Fukunaga, Koichi
Sano, Akiko
Iwanaga, Takashi
Higashimoto, Yuji
Matsumoto, Masataka
Takatsuki, Kiyonobu
Nagata, Kazuma
Tachikawa, Ryo
Tomii, Keisuke
Kaneko, Masahiro
Tomioka, Hiromi
Nagano, Tatsuya
Yamane, Mayuka
Yoshida, Chieko
Sakagami, Takuro
Seto, Yurie
Kaneko, Yoshiko
Takayama, Koichi
Terada, Satoru
Nishi, Kenta
Tajiri, Tomoko
Nakamura, Saya
Wakahara, Keiko
Ito, Takefumi
Nakano, Takako
Yamashita, Takafumi
Takata, Shohei
Seri, Yoshihiro
Mizumori, Yasuyuki
Tsukamoto, Hiroaki
Kagami, Ryogo
Nakahara, Yasuharu
Ishii, Yukio
Kita, Toshiyuki
Hidaka, Kouko
Minakuchi, Masayoshi
Tsuboi, Tomomasa
Tamaki, Shinji
Matsuki, Takanori
Kida, Hiroshi
Tomita, Katsuyuki
Abe, Takashi
Shindoh, Joe
Taniguchi, Akihiko
Azuma, Masato
Kataoka, Mikio
Ogawa, Haruhiko
Matsumoto, Takeshi
Aihara, Kensaku
Nakagome, Kazuyuki
Miyajima, Satsuki
Hashimoto, Kentaro
Shiota, Tetsuhiro
Yamaguchi, Masafumi
Nakano, Yasutaka
Otsuka, Kojiro
Yasuo, Masanori
Hanaoka, Masayuki
Yamada, Takashi
Shirai, Toshihiro
Iwasaki, Yoshinobu
Mineshita, Masamichi
Tsuburai, Takahiro
Komase, Yuko
Koh, Hidefumi
Hasegawa, Koichi
Kita, Hideo
Murakami, Koji
Sugiura, Hisatoshi
Ichinose, Masakazu
Kutsuzawa, Tomoko
Oguma, Tsuyoshi
Tanaka, Jun
Kono, Yuta
Abe, Shinji
Nakamura, Morio
Orimo, Mami
Tagaya, Etsuko
Matsuda, Toshiaki
Harada, Tomoya
Iijima, Hiroaki
Kawabata, Hiroki
Yatera, Kazuhiro
Masuko, Hironori
Morishima, Yuko
Nakanishi, Masanori
Yamamoto, Nobuyuki
Inoue, Sumito
Hamada, Kazuki
Yamaji, Yoshikazu
Hirano, Tsunahiko
Matsunaga, Kazuto
-
Funding
Funding for this research was provided by:
Scientific Assembly of Allergy, Immunology and Inflammation, Japanese Respiratory Society
Novartis Japan
- License Information
-
More Information
Article History
Received: 29 August 2022
Accepted: 10 December 2022
First Online: 20 December 2022
Declarations
:
: This study was approved by the Kyoto University Medical Ethics Committee (R2168). Given the retrospective nature of the study and the use of anonymous patient data, requirements for written informed consent were waived.
: Not applicable.
: HM received lecturer fees from Novartis Japan, Sanofi K.K., AstraZeneca K.K., GlaxoSmithKline, Kyorin Pharmaceutical Co. and Boehringer Ingelheim received grants from Kyorin Pharmaceutical Co., Boehringer Ingelheim and Teijin Pharma outside the submitted work as well as received support from the Japanese Respiratory Society and Research Grant from Novartis Japan. AY received lecturer fees from AstraZeneca K.K., Novartis Japan, GlaxoSmithKline, Sanofi K.K. and Boehringer Ingelheim. YN received lecturer fees from Novartis Japan, AstraZeneca K.K. and Kyorin Pharmaceutical Co. KA received lecturer fees from Novartis Japan, Sanofi K.K., AstraZeneca K.K., GlaxoSmithKline plc and Boehringer Ingelheim Japan Inc. AN received lecturer fees from AstraZeneca K.K., Kyorin Pharmaceutical Co. and Novartis and received consulting fees from MSD. YT received lecturer fees from Kyorin Pharmaceutical Co., Teijin Pharma, Novartis Japan, Sanofi and AstraZeneca, received consulting fees from GlaxoSmithKline and Kyorin Pharmaceutical Co., and received grants from Kyorin Pharmaceutical Co., Astellas, Taiho, Boehringer Ingelheim and Teijin Pharma. NHar received lecturer fees from AstraZeneca K.K., GlaxoSmithKline K.K., Novartis Pharma K. K. and Sanofi K.K. and received grants from AstraZeneca K.K., Kyorin Pharmaceutical Co., Daikin (China) Investment Co., Ltd., Kao Corporation, SRL Medisearch Inc. and TOSOH Corporation. MN received lecturer fees from AstraZeneca K.K., GlaxoSmithKline K.K. and Torii Pharmaceutical Co. Ltd. HI received lecturer fees and/or advisory board from Astellas, AstraZeneca, Boehringer-Ingelheim, Fukuda-Denshi, GlaxoSmithKline, Kracie, Kyorin, Novartis, Omron, Pfizer and Sanofi and received research grants and support to Kagoshima University from Asahi-Kasei Pharma, AstraZeneca, Boehringer-Ingelheim, Chugai, GlaxoSmithKline, Kyorin, Otsuka, Teijin, Taiho and Ono. NM received lecturer fees from AstraZeneca K.K., GlaxoSmithKline K.K., Novartis Pharma K.K. and Nippon Boehringer Ingelheim Co., Ltd. Nhi received lecturer fees from AstraZeneca, GlaxoSmithKline and Novartis and received grants from GlaxoSmithKline and Novartis. MH received lecturer fees from AstraZeneca, GlaxoSmithKline and Novartis Pharma. Nhat received lecturer fees from AstraZeneca, GlaxoSmithKline, Novartis Pharma and Sanofi. Nhas received lecturer fees from AstraZeneca, GlaxoSmithKline, Novartis and Boehringer Ingelheim and received a research grant from Boehringer Ingelheim outside the submitted work. TK received lecturer fees from GlaxoSmithKline plc., Sanofi K.K., Nippon Boehringer Ingelheim Co., Ltd., Astra Zeneca K.K, Eli Lilly Japan K.K, Chugai Pharmaceutical Co., Ltd., Novartis Pharma K.K., Meiji Seika Pharma Co., Ltd., Bristol Myers Squibb, DAIICHI SANKYO COMPANY, LIMITED and TEIJIN PHARMA LIMITED. OM received lecturer fees from AstraZeneca, GlaxoSmithKline, Novartis Pharma and Sanofi. TO received lecturer fees from AstraZeneca K.K., GlaxoSmithKline plc., Boehringer Ingelheim Japan Inc., Kyorin Pharmaceutical Co., Novartis Japan and Sanofi K.K. HS belongs to the endowed chair supported by Phillips-Respironics, ResMed, Fukuda Denshi and Fukuda Lifetec Keiji.
